[1]
Daniela C. Andrade, “Insulin-like growth factor-1 short-period therapy improves Non-Alcoholic Fatty Liver Disease (NAFLD) in obese mice”, BJHBS, vol. 22, nº 2, p. 81–90, dez. 2023.